PASITHEA THERAPEUTICS CORP. Additional Liability, Long-Duration Insurance, after Reinsurance
PASITHEA THERAPEUTICS CORP. (KTTA) had Additional Liability, Long-Duration Insurance, after Reinsurance of $392.00 thousand as of 2023-01-09, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Financial Services › Insurance
us-gaap:AdditionalLiabilityLongDurationInsuranceAfterReinsurance · last filed 2023-11-13
- 2023-01-09: Additional Liability, Long-Duration Insurance, after Reinsurance $392.00K.
| Period end | Additional Liability, Long-Duration Insurance, after Reinsurance |
|---|---|
| 2023-01-09 | $392.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |